- Entry
- $3.95
- Now
- $7.38 +86.8%
- Target
- —
- Score
- —
I bought some IBRC during the recent move +35% today and wanted to check the thesis. I'm trying to understand if the latest news reflects a durable inflection point or might I have been better off lighting the cash on fire. What caught my attention was that the company is no longer just "pipeline someday" speculation. They have a marketed product (ANKTIVA) in bladder cancer, and there have been additional regulatory/clinical updates that are clearly driving interest. Does the current …
— ORIGINAL POST ·
Looking for a fundamentals view on IBRX after recent catalysts
· r/investing
· Jan 16, 2026